"Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures Outside the Walls by Dual Screening Method RTDs and FibroScan®"
RecruitingOBSERVATIONAL
Enrollment
2,300
Participants
Timeline
Start Date
June 5, 2025
Primary Completion Date
June 5, 2035
Study Completion Date
June 5, 2035
Conditions
Viral Hepatitis
Trial Locations (1)
87000
RECRUITING
Limoges University Hospital, Limoges
All Listed Sponsors
lead
University Hospital, Limoges
OTHER
NCT06904820 - "Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures Outside the Walls by Dual Screening Method RTDs and FibroScan®" | Biotech Hunter | Biotech Hunter